Home  »  Stock   »  Buying a ADMA Biologics Inc. (ADMA) is possibly th...

Buying a ADMA Biologics Inc. (ADMA) is possibly the most advantageous right now

Let’s start up with the current stock price of ADMA Biologics Inc. (ADMA), which is $2.56 to be very precise. The Stock rose vividly during the last session to $2.71 after opening rate of $2.62 while the lowest price it went was recorded $2.5444 before closing at $2.62.Recently in News on August 10, 2022, ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update. 2Q2022 Total Revenues Were $33.9 Million, a 90% Y-o-Y Increase. You can read further details here

ADMA Biologics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.92 on 09/08/22, with the lowest value was $1.26 for the same time period, recorded on 01/13/22.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


ADMA Biologics Inc. (ADMA) full year performance was 104.80%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ADMA Biologics Inc. shares are logging -12.33% during the 52-week period from high price, and 153.47% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.01 and $2.92.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3266354 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the ADMA Biologics Inc. (ADMA) recorded performance in the market was 81.56%, having the revenues showcasing 19.07% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 514.02M, as it employees total of 527 workers.

Specialists analysis on ADMA Biologics Inc. (ADMA)

During the last month, 0 analysts gave the ADMA Biologics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.21, with a change in the price was noted +0.67. In a similar fashion, ADMA Biologics Inc. posted a movement of +35.45% for the period of last 100 days, recording 2,816,744 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ADMA is recording 1.22 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.22.

Trends and Technical analysis: ADMA Biologics Inc. (ADMA)

Raw Stochastic average of ADMA Biologics Inc. in the period of last 50 days is set at 62.11%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 9.82%. In the last 20 days, the company’s Stochastic %K was 22.77% and its Stochastic %D was recorded 32.52%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 81.56%. Additionally, trading for the stock in the period of the last six months notably improved by 60.00%, alongside a boost of 104.80% for the period of the last 12 months. The shares increased approximately by -7.25% in the 7-day charts and went down by 2.81% in the period of the last 30 days. Common stock shares were driven by 19.07% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts